Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Central obesity measures of waist circumference and waist-to-hip ratio appear to be more accurate and consistent indicators ...

Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...

A new study from Zurich and Leipzig reveals why some obese people remain healthy while others develop metabolic diseases. The research highlights key differences in fat type, cell behaviour, and ...

Neurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

A recent analysis by charity body Diabetes UK has revealed that a sobering one in five adults in the UK – totalling 12.2 million people – are living with diabetes or pre-diabetes. This includes 4.6 ...

Africa's leading public health official will write to the U.S. Secretary of State on Thursday to highlight how the U.S. aid ...

As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC. New research from the ...